Penumbra, Inc. to Host Investor Event and Q3 Earnings Call

Penumbra, Inc., a leading company in thrombectomy technology, announced it will host an investor event on October 26, 2025, during the 2025 Transcatheter Cardiovascular Therapeutics (TCT) Conference. The event is scheduled from 4:00 PM to 5:00 PM Pacific Time (7:00 PM to 8:00 PM Eastern Time).

Management, along with members of the STORM-PE steering committee, will discuss the company’s clinical trial focused on pulmonary embolism. Following the presentation, attendees will have the opportunity to participate in a question-and-answer session. For those unable to attend in person, a live webcast will be available on the “Events and Presentations” section of the company’s website at www.penumbrainc.com. The webcast will remain accessible for at least two weeks after the event.

In addition to the investor event, Penumbra also announced it will release its financial results for the third quarter of 2025. This conference call will occur on November 5, 2025, at 4:30 PM Eastern Time, following the market’s close. A press release detailing the financial results will be published after the market close that same day. Investors can join the call by dialing (888) 596-4144 and entering the conference ID: 6572573. The conference call will also be accessible via a webcast on the company’s website, available for at least two weeks following the call.

About Penumbra, Inc.

Founded in Alameda, California, Penumbra, Inc. specializes in innovative medical technologies addressing complex conditions such as ischemic stroke and venous thromboembolism. The company’s extensive portfolio includes computer-assisted vacuum thrombectomy (CAVT) systems, designed to efficiently and safely remove blood clots throughout the body.

By pioneering advancements in thrombectomy technology, Penumbra supports healthcare providers across more than 100 countries, aiming to enhance patient outcomes and quality of life. For further information, visit www.penumbrainc.com and connect with the company on social media platforms including Instagram, LinkedIn, and X.

For investor inquiries, please contact Penumbra, Inc. at [email protected].